Alivus Life Sciences Complete Financial Statements
ALIVUS • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2018
Complete Financial Data Export
Export complete financial statements for Alivus Life Sciences (ALIVUS).
Downloads include all available records across all periods.
For market performance, see the
ALIVUS stock price today
.
Profitability Ratios
Net Profit Margin
20.07%
2025 data
EBITDA Margin
29.62%
2025 data
Operating Margin
29.00%
2025 data
Return on Assets
14.25%
2025 data
Return on Equity
17.25%
2025 data
Balance Sheet Ratios
Current Ratio
18.83
2025 data
Debt to Equity
1.21
2025 data
Equity Ratio
82.59%
2025 data
Asset Turnover
0.71
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+4.3%
Year-over-Year
Net Profit Growth
+9.1%
Year-over-Year
EBITDA Growth
+9.5%
Year-over-Year
Expense Growth
+2.2%
Year-over-Year
Assets Growth
+19.7%
Year-over-Year
Equity Growth
+20.8%
Year-over-Year
Liabilities Growth
+19.7%
Year-over-Year
Operating Cash Flow Growth
-5.3%
Year-over-Year
Investing Cash Flow Growth
-426.5%
Year-over-Year
Financing Cash Flow Growth
+97.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,525 | 2,421 | 2,295 | 2,190 | 2,138 | 1,886 | 1,549 | 887 | 0 |
| Expenses | 1,741 | 1,704 | 1,609 | 1,519 | 1,507 | 1,294 | 1,065 | 639 | 0 |
| EBITDA | 785 | 717 | 686 | 671 | 631 | 592 | 484 | 248 | 0 |
| Operating Profit Margin % | 30.00% | 29.00% | 30.00% | 30.00% | 29.00% | 31.00% | 31.00% | 28.00% | -5.00% |
| Depreciation | 67 | 61 | 54 | 42 | 38 | 33 | 29 | 19 | 0 |
| Interest | 4 | 2 | 2 | 1 | 28 | 88 | 34 | 1 | 0 |
| Profit Before Tax | 714 | 654 | 631 | 629 | 565 | 471 | 421 | 228 | 0 |
| Tax | 174 | 169 | 160 | 162 | 146 | 119 | 108 | 33 | 0 |
| Net Profit | 530 | 486 | 471 | 467 | 419 | 352 | 313 | 196 | 0 |
| Earnings Per Share (₹) | 43.30 | 39.63 | 38.43 | 38.11 | 35.63 | 32.61 | 29.04 | 24.64 | -7.89 |
Related Pages for Alivus Life Sciences
Additional stock information and data for ALIVUS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 3,411 | 2,850 | 2,702 | 2,471 | 1,997 | 1,726 | 1,475 | 0 |
| Current Assets | 2,335 | 1,916 | 1,850 | 1,765 | 1,399 | 1,160 | 931 | 0 |
| Fixed Assets | 955 | 805 | 781 | 590 | 573 | 546 | 456 | 0 |
| Capital Work in Progress | 102 | 106 | 62 | 97 | 14 | 11 | 80 | 0 |
| Investments | 478 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,877 | 1,939 | 1,860 | 1,784 | 1,410 | 1,169 | 939 | 0 |
| LIABILITIES | ||||||||
| Total Liabilities | 3,411 | 2,850 | 2,702 | 2,471 | 1,997 | 1,726 | 1,475 | 0 |
| Current Liabilities | 124 | 79 | 67 | 33 | 23 | 16 | 7 | 0 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 2,817 | 2,332 | 2,138 | 2,054 | 753 | 402 | 88 | -1 |
| Share Capital | 25 | 25 | 25 | 25 | 2 | 2 | 2 | 0 |
| Reserves & Surplus | 2,793 | 2,308 | 2,114 | 2,030 | 751 | 400 | 86 | -1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 392 | 414 | 306 | 598 | 388 | 195 | 10 | -1 |
| Investing Activities | -616 | -117 | -147 | -122 | -69 | -51 | -9 | 0 |
| Financing Activities | -6 | -279 | -388 | -79 | -214 | -137 | 1 | 1 |
| Net Cash Flow | -230 | 18 | -228 | 397 | 106 | 8 | 2 | 0 |